Literature DB >> 31701167

[Surgical treatment of malignant biliary tract diseases].

M Schmelzle1, W Schöning2, J Pratschke2.   

Abstract

BACKGROUND: Cancer of the intrahepatic and extrahepatic biliary tracts is characterized by a low incidence and a very heterogeneous appearance.
OBJECTIVE: Summary and evaluation of current surgical strategies in the treatment of malignant biliary tract diseases.
MATERIAL AND METHODS: An analysis of English language publications as well as European and American guidelines and recommendations for the surgical treatment of malignant diseases of the biliary tract was carried out. The results and recommendations were summarized and evaluated on the basis of experiences in this center.
RESULTS: Surgery is considered to be the only curative treatment option; however, prospective randomized studies and existing guidelines are based on limited evidence. Surgical strategies and the extent of resection differ between carcinomas of the intrahepatic and extrahepatic bile ducts depending on localization, size and number of lesions as well as their proximity to surrounding structures.
CONCLUSION: Sufficient experience in the treatment of these rare tumors is of special importance for the implementation of individualized overall concepts and for the sufficient performance of the mostly complex resections.

Entities:  

Keywords:  Biliary tract cancer; Cholangiocarcinoma; Liver surgery; Liver transplantation; Pancreatic surgery

Year:  2020        PMID: 31701167     DOI: 10.1007/s00104-019-01062-0

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  19 in total

1.  The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium.

Authors:  Neal Bhutiani; Charles R Scoggins; Kelly M McMasters; Cecilia G Ethun; George A Poultsides; Timothy M Pawlik; Sharon M Weber; Carl R Schmidt; Ryan C Fields; Kamran Idrees; Ioannis Hatzaras; Perry Shen; Shishir K Maithel; Robert C G Martin
Journal:  Surgery       Date:  2018-01-03       Impact factor: 3.982

2.  Major hepatectomy in Bismuth types I and II hilar cholangiocarcinoma.

Authors:  Junjie Xiong; Quentin M Nunes; Wei Huang; Ailin Wei; Nengwen Ke; Gang Mai; Xubao Liu; Weiming Hu
Journal:  J Surg Res       Date:  2014-10-22       Impact factor: 2.192

3.  Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

Authors:  John N Primrose; Richard P Fox; Daniel H Palmer; Hassan Z Malik; Raj Prasad; Darius Mirza; Alan Anthony; Pippa Corrie; Stephen Falk; Meg Finch-Jones; Harpreet Wasan; Paul Ross; Lucy Wall; Jonathan Wadsley; Jeff T R Evans; Deborah Stocken; Raaj Praseedom; Yuk Ting Ma; Brian Davidson; John P Neoptolemos; Tim Iveson; James Raftery; Shihua Zhu; David Cunningham; O James Garden; Clive Stubbs; Juan W Valle; John Bridgewater
Journal:  Lancet Oncol       Date:  2019-03-25       Impact factor: 41.316

4.  Cholangiographic Tumor Classification for Simple Patient Selection Prior to Hepatopancreatoduodenectomy for Cholangiocarcinoma.

Authors:  Yoshitaka Toyoda; Tomoki Ebata; Takashi Mizuno; Yukihiro Yokoyama; Tsuyoshi Igami; Junpei Yamaguchi; Shunsuke Onoe; Nobuyuki Watanabe; Masato Nagino
Journal:  Ann Surg Oncol       Date:  2019-05-17       Impact factor: 5.344

5.  High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry.

Authors:  Pim B Olthof; Robert J S Coelen; Jimme K Wiggers; Bas Groot Koerkamp; Massimo Malago; Roberto Hernandez-Alejandro; Stefan A Topp; Marco Vivarelli; Luca A Aldrighetti; Ricardo Robles Campos; Karl J Oldhafer; William R Jarnagin; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2017-03-06       Impact factor: 3.647

6.  Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.

Authors:  Peter Neuhaus; Armin Thelen; Sven Jonas; Gero Puhl; Timm Denecke; Wilfried Veltzke-Schlieker; Daniel Seehofer
Journal:  Ann Surg Oncol       Date:  2011-10-01       Impact factor: 5.344

7.  Minimally Invasive Liver Surgery in Elderly Patients-A Single-Center Experience.

Authors:  Simon Wabitsch; Philipp Konstatnin Haber; Nnange Ekwelle; Anika Kästner; Felix Krenzien; Christian Benzing; Georgi Atanasov; Julia-Sophia Bellingrath; Georg Bauer; Wenzel Schöning; Robert Öllinger; Johann Pratschke; Moritz Schmelzle
Journal:  J Surg Res       Date:  2019-02-26       Impact factor: 2.192

8.  Mortality after liver surgery in Germany.

Authors:  N Filmann; D Walter; E Schadde; C Bruns; T Keck; H Lang; K Oldhafer; H J Schlitt; M R Schön; E Herrmann; W O Bechstein; A A Schnitzbauer
Journal:  Br J Surg       Date:  2019-07-24       Impact factor: 6.939

9.  Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.

Authors:  Julien Edeline; Meher Benabdelghani; Aurélie Bertaut; Jérôme Watelet; Pascal Hammel; Jean-Paul Joly; Karim Boudjema; Laetitia Fartoux; Karine Bouhier-Leporrier; Jean-Louis Jouve; Roger Faroux; Véronique Guerin-Meyer; Jean-Emmanuel Kurtz; Eric Assénat; Jean-François Seitz; Isabelle Baumgaertner; David Tougeron; Christelle de la Fouchardière; Catherine Lombard-Bohas; Eveline Boucher; Trevor Stanbury; Christophe Louvet; David Malka; Jean-Marc Phelip
Journal:  J Clin Oncol       Date:  2019-02-01       Impact factor: 44.544

10.  Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis.

Authors:  Andreas Andreou; Benjamin Struecker; Nathanael Raschzok; Felix Krenzien; Philipp Haber; Simon Wabitsch; Christoph Waldbaur; Eva-Maria Touet; Anne-Christine Eichelberg; Georgi Atanasov; Matthias Biebl; Marcus Bahra; Robert Öllinger; Moritz Schmelzle; Johann Pratschke
Journal:  Surg Oncol       Date:  2018-10-09       Impact factor: 3.279

View more
  1 in total

Review 1.  Prognostic and Predictive Molecular Markers in Cholangiocarcinoma.

Authors:  Sandra Pavicevic; Sophie Reichelt; Deniz Uluk; Isabella Lurje; Cornelius Engelmann; Dominik P Modest; Uwe Pelzer; Felix Krenzien; Nathanael Raschzok; Christian Benzing; Igor M Sauer; Sebastian Stintzing; Frank Tacke; Wenzel Schöning; Moritz Schmelzle; Johann Pratschke; Georg Lurje
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.